
    
      The aim is to assess the impact of anti-PARP on peripheral immune populations and the amount
      of DNA circulating; to correlate these data with tumor infiltration, with the initial
      clinical characteristics and with the clinical course; compare the immunogenic effect of
      different anti-PARPs.
    
  